Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells

Brain

Volumn 128, Issue 3, 2005, Pages 540-549

  Bachelin, Corinne ^a   Lachapelle, François ^a   Girard, Christelle ^a   Moissonnier, Pierre ^c   Serguera Lagache, Che ^b   Mallet, Jacques ^b   Fontaine, Denys ^a   Chojnowski, Alexandre ^a   Le Guern, Eric ^a   Nait Oumesmar, Brahim ^a   Baron Van Evercooren, Anne ^a,d  

^a INSERM   (France)

^b CNRS   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CNS; Primate; Remyelination; Schwann cell

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CELL TRANSPLANTATION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRON MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACACA; MALE; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NUDE MOUSE; OLIGODENDROGLIA; PERIPHERAL NERVE; PRIORITY JOURNAL; SCHWANN CELL; SIGNAL TRANSDUCTION; SPINAL CORD; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODEL; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; MYELIN SHEATH; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY; SPINAL CORD DISEASE; TRANSPLANTATION; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; HIV; MACACA FASCICULARIS; MALE; MICE; MICE, NUDE; MYELIN SHEATH; NERVE REGENERATION; SCHWANN CELLS; SPINAL CORD; SPINAL CORD DISEASES; TRANSDUCTION, GENETIC;

EID: 20144377560     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh406     Document Type: Article

References (50)

1. Avellana-Adalid V, Bachelin C, Lachapelle F, Escriou C, Ratzkin B, Baron-Van Evercooren A. In vitro and in vivo behaviour of NDF-expanded monkey Schwann cells. Eur J Neurosci 1998; 10: 291-300.
2. Baron-Van Evercooren A, Blakemore WF. Remyelination through engraftment. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego (CA): Elsevier Academic Press; 2003. p. 143-72.
3. Baron-Van Evercooren A, Gansmuller A, Gumpel M, Baumann N, Kleinman HK. Schwann cell differentiation in vitro: extracellular matrix deposition and interaction. Dev Neurosci 1986; 8: 182-96.
4. Baron-Van Evercooren A, Gansmuller A, Clerin E, Gumpel M. Hoechst 33342 a suitable fluorescent marker for Schwann cells after transplantation in the mouse spinal cord. Neurosci Lett 1991; 131: 241-4.
5. Baron-Van Evercooren A, Avellana-Adalid V, Lachapelle F, Liblau R. Schwann cell transplantation and myelin repair of the CNS. Mult Scler 1997; 3: 157-61.
6. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003; 206: 165-71.
7. Blakemore WF, Franklin RJ. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant 2000; 9: 289-94.
8. Bottenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979; 76: 514-7.
9. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285: 754-6.
10. Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, et al. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 1998; 71: 1765-8.
11. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 1957; 46: 208-9.
12. Feltri ML, Scherer SS, Wrabetz L, Kamholz J, Shy ME. Mitogen-expanded Schwann cells retain the capacity to myelinate regenerating axons after transplantation into rat sciatic nerve. Proc Natl Acad Sci USA 1992; 89: 8827-31.
13. Franklin RJ. Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull 2002; 57: 827-32.
14. Franklin RJ, Zhao C, Sim FJ. Ageing and CNS remyelination. Neuroreport 2002; 13: 923-8.
15. Ghatak NR, Hirano A, Doron Y, Zimmerman HM. Remyelination in multiple sclerosis with peripheral type myelin. Arch Neurol 1973; 29: 262-7.
16. Gout O, Gansmuller A, Baumann N, Gumpel M. Remyelination by transplanted oligodendrocytes of a demyelinated lesion in the spinal cord of the adult shiverer mouse. Neurosci Lett 1988; 87: 195-9.
17. Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 1972; 10: 535-46.
18. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Muller HW. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia 1998; 23: 89-98.
19. Harrison B. Schwann cell and oligodendrocyte remyelination in lysolecithin-induced lesions in irradiated rat spinal cord. J Neurol Sci 1985; 67: 143-59.
20. Honmou O, Felts PA, Waxman SG, Kocsis JD. Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J Neurosci 1996; 16: 3199-208.
21. Imaizumi T, Lankford KL, Baron-Van Evercooren A, Kocsis JD. electrophysiological properties of spinal cord axons remyelinated by various cell transplantation conditions. J Neurosci 1999; 292: 737.
22. Imaizumi T, Lankford KL, Kocsis JD. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res 2000; 854: 70-8.
23. Itoyama Y, Webster HD, Richardson EP Jr, Trapp BD. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 1983; 14: 339-46.
24. Iwashita Y, Fawcett JW, Crang AJ, Franklin RJ, Blakemore WF. Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. Exp Neurol 2000; 164: 292-302.
25. Jasmin L, Janni G, Moallem TM, Lappi DA, Ohara PT. Schwann cells are removed from the spinal cord after effecting recovery from paraplegia. J Neurosci 2000; 20: 9215-23.
26. Jeffery ND, Blakemore WF. Locomotor deficit induced in experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 1997; 120: 27-37.
27. Kohama I, Lankford KL, Preiningerova J, White FA, Vollmer TL, Kocsis JD. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001; 21: 944-50.
28. Kerschensteiner M, Stadelmann C, Buddenberg BS, Merkler D, Bareyre FM, Anthony DC, et al. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 2004; 164: 1455-69.
29. Langford LA, Owens GC. Resolution of the pathway taken by implanted Schwann cells to a spinal cord lesion by prior infection with a retrovirus encoding beta-galactosidase. Acta Neuropathol 1990; 80: 514-20.
30. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, et al. The influence of heregulins on human Schwann cell proliferation. J Neurosci 1995; 15: 1329-40.
31. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
32. Morgan L, Jessen KR, Mirsky R. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition. J Cell Biol 1991; 112: 457-67.
33. Mosahebi A, Woodward B, Wiberg M, Martin R, Terenghi G. Retroviral labeling of Schwann cells: in vitro characterization and in vivo transplantation to improve peripheral nerve regeneration. Glia 2001; 34: 8-17.
34. Murray PD, McGavern DB, Sathornsumetee S, Rodriguez M. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain 2001; 124: 1403-16.
35. Pedraza L, Colman DR. Fluorescent myelin proteins provide new tools to study the myelination process. J Neurosci Res 2000; 60: 697-703.
36. Porter S, Clark MB, Glaser L, Bunge RP. Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J Neurosci 1986; 6: 3070-8.
37. Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979; 5: 22-31.
38. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503.
39. Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-204.
40. Raine CS, Traugott U, Stone SH. Glial bridges and Schwann cell migration during chronic demyelination in the CNS. J Neurocytol 1978; 7: 541-53.
41. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 1982; 79: 2709-13.
42. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI. Purification and expansion of human Schwann cells in vitro. Nat Med 1995; 1: 80-3.
43. Seamon KB, Daly JW. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 1981; 7: 201-24.
44. Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 1981; 83: 311-27.
45. Stewart HJ, Bradke F, Tabernero A, Morrell D, Jessen KR, Mirsky R. Regulation of rat Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro. Eur J Neurosci 1996; 8: 553-64.
46. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB. Schwann cell but not olfactory ensheathing glia transplants improve hind-limb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci 2002; 22: 6670-81.
47. Yoshimura K, Negishi T, Kaneko A, Sakamoto Y, Kitamura K, Hosokawa T, et al. Monoclonal antibodies specific to the integral membrane protein P0 of bovine peripheral nerve myelin. Neurosci Res 1996; 25: 41-9.
48. Zanazzi G, Einheber S, Westreich R, Hannocks MJ, Bedell-Hogan D, Marchionni MA, et al. Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol 2001; 152: 1289-99.
49. Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J, et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001; 19: 446-50.
50. Zhang SC, Duncan ID. Remyelination and restoration of axonal function by glial cell transplantation. Prog Brain Res 2000; 127: 515-33.